Imvotamab
Product Specifications
CAS Number
2573121-53-4
Bioactivity
Imvotamab (IGM-2323), a CD20xCD3 bispecific IGM antibody featuring a dual-action mechanism, promotes physiological T cell activation to avoid both over-stimulation and immune function down-regulation. This compound is under development for addressing B-cell malignant tumors, including multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL) [1] [2] [3] [4].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1065129-01 250 mg
4-Methyl-N, N-di (prop-2-yn-1-yl) benzenesulfonamide
Sign In for Pricing
View Details OR1065129-02 1 g
4-Methyl-N, N-di (prop-2-yn-1-yl) benzenesulfonamide
Sign In for Pricing
View Details